Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Bevacizumab|DRUG: Fulvestrant
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Hoffmann-La Roche|German Breast Group